soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Presented at ACC.25: Among participants with type 2 diabetes and disease, chronic kidney disease, or both, (14 mg) was associated with a lower risk of cardiovascular events than placebo SELECT Trial

If you're pregnant, breastfeeding, or on medication, it's best to consult a healthcare professional before taking any supplements

There is tremendous excitement that triple therapy may finally allow us to address the multiple metabolic factors that affect people who are obese whether or not they have type 2 diabetes

AHK-Cu (L-Ala-L-His-L-Lys-Cu 2+ ) has also been shown to promote the growth of DPCs in vitro and the ex vivo elongation of human HFs, although its specific signaling mechanism is less well characterized than GHK-Cu [23]

Rapid weight loss often leads to significant lean mass loss, which can negatively affect metabolism, bone density, and long term strength

Unlike traditional methods, medical weight loss provides a structured and supportive environment to achieve long-term results

Omega-3 for hormone balance, brain and eye function